P Le, G Romano, P Nana-Sinkam, M Acunzo - Cancers, 2021 - mdpi.com
Simple Summary Researchers have spent nearly two decades unraveling the roles of non- coding RNAs in cancer biology. In recent years, deep transcriptomic profiling of tissue and …
H Tang, Y Gao, Z Li, Y Miao, Z Huang… - Clinical and …, 2020 - Wiley Online Library
Background COVID‐19 is currently a global pandemic, but the response of human immune system to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection …
Abstract Background Coronavirus disease 2019 (COVID-19) caused by a novel betacoronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Despite robust literature associating IL-31 with pruritic inflammatory skin diseases, its influence on cutaneous inflammation and the interplay between inflammatory and …
C Li, R Wang, A Wu, T Yuan, K Song, Y Bai… - BMC Medical …, 2022 - Springer
Background MicroRNAs (miRNAs) are a class of small non-coding RNA that can downregulate their targets by selectively binding to the 3′ untranslated region (3′ UTR) of …
J Dong, WJ Huth, N Marcel, Z Zhang, LL Lin… - Journal of Experimental …, 2023 - rupress.org
Effector regulatory T cells (eTregs) exhibit distinct homeostatic properties and superior suppressor capacities pivotal for controlling immune responses mediated by their …
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had a tremendous impact worldwide. Mapping virus-host interactions is critical to understand …
Chimeric antigen receptor (CAR) T cell therapy has led to a paradigm shift in cancer immunotherapy, but still several obstacles limit CAR T cell efficacy in cancers. Advances in …
The COVID-19 pandemic has been a public health issue around the world in the last few years. Currently, there is no specific antiviral treatment to fight the disease. Thus, it is …